{
    "SPADE_UN_13511": {
        "Clinical Information": [],
        "Patent Information": [],
        "Sequence Information": {
            "SPADE ID": "SPADE_UN_13511",
            "Peptide Name": "EKL0C",
            "Source": "Synthetic construct",
            "Family": "Not found",
            "Gene": "Not found",
            "Sequence": "SLDQINVTFLDLEYEMKKLEEAIKKLEESYIDLKELGTYEYYVKWGSGC",
            "Sequence Length": 49,
            "UniProt Entry": "No entry found",
            "Protein Existence": "Not found",
            "Biological Activity": [
                "Antimicrobial",
                "Antiviral(SARS-CoV-2)"
            ],
            "Target Organism": "[Ref.34367893]Virus:SARS-CoV-2:Inhibition of Pseudovirus(PsV) infection in Huh-7 cells(IC50=0.122±0.012 μmol/L),Inhibition of Pseudovirus(PsV) infection in 293T/ACE2 cells(IC50=0.147±0.055 μmol/L),Inhibition of Pseudovirus(PsV) infection in Caco-2 cells(IC50=0.162±0.022 μmol/L),inhibition of cell-cell fusion(IC50=0.021±0.003 μmol/L).",
            "Hemolytic Activity": "No hemolysis information or data found in the reference(s) presented in this entry",
            "Cytotoxicity": "No cytotoxicity information found in the reference(s) presented",
            "Binding Target": "liposomes",
            "Linear/Cyclic": "Linear",
            "N-terminal Modification": "Free",
            "C-terminal Modification": "Chol",
            "Stereochemistry": "L",
            "Structure Description": "Not found",
            "Formula": "C266H408N58O84S2",
            "Mass": 5826.55,
            "PI": 4.44,
            "Net Charge": -5,
            "Hydrophobicity": -0.49,
            "Half Life": "Mammalian:1.9 hourYeast:>20 hourE.coli:>10 hour",
            "Comments": "The peptide targets a highly conserved target site in HR1 domains in S protein of HCoVs.",
            "Literature": [
                {
                    "Title": "A highly potent and stable pan-coronavirus fusion inhibitor as a candidate prophylactic and therapeutic for COVID-19 and other coronavirus diseases.",
                    "Pubmed ID": "34367893",
                    "Reference": "Acta Pharm Sin B. 2021 Aug 2.",
                    "Author": "Zhou J, Xu W, Liu Z, Wang C, Xia S, Lan Q, Cai Y, Su S, Pu J, Xing L, Xie Y, Lu L, Jiang S, Wang Q.",
                    "URL": "http://www.ncbi.nlm.nih.gov/pubmed/?term=34367893"
                }
            ],
            "Frequent Amino Acids": "ELK",
            "Absent Amino Acids": "HOPRU",
            "Basic Residues": 6,
            "Acidic Residues": 11,
            "Hydrophobic Residues": 21,
            "Polar Residues": 22,
            "Positive Residues": 6,
            "Negative Residues": 11,
            "Similar Sequences": [
                {
                    "SPADE_ID": "SPADE_UN_13502",
                    "Similarity": 1.0,
                    "Sequence": "SLDQINVTFLDLEYEMKKLEEAIKKLEESYIDLKEL"
                },
                {
                    "SPADE_ID": "SPADE_UN_13507",
                    "Similarity": 1.0,
                    "Sequence": "SLDQINVTFLDLEYEMKKLEEAIKKLEESYIDLKELGTYEYYVKW"
                },
                {
                    "SPADE_ID": "SPADE_UN_13506",
                    "Similarity": 1.0,
                    "Sequence": "NVTFLDLEYEMKKLEEAIKKLEESYIDLKELGTYEYGSGC"
                }
            ]
        }
    }
}